Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model
Journal of Investigative Dermatology · 2025-04 · 145 (4) · 883-896
DOI: 10.1016/j.jid.2024.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-04. Verfasst von Nathaniel B Goldstein und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Melanocytes, Phosphodiesterase 4 Inhibitors, Vitiligo, Skin Pigmentation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Pfizer, University of Colorado, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Vitiligo is a common chronic autoimmune disease characterized by white macules and patches of the skin, having a negative impact on patients' life and without any definitive cure at present. Identification of new compounds to reverse depigmentation is therefore a pressing need for this disease. The pharmacologic compounds phosphodiesterase-4 inhibitors (PDE4is) are small molecules with immunomodulatory properties used for treatment of inflammatory dermatoses. PDE4is have shown repigmentation effects in patients with vitiligo, in some case reports. We characterized the proliferative and melanogenic potential of 2 known PDE4is-crisaborole and roflumilast-and of a more recently designed compound, PF-07038124. We used 2 in vitro model systems-the primary human melanocyte culture and a 3-dimensional cocultured skin model (MelanoDerm)-with an exploratory testing platform composed of complementary assays (spectrophotometry, melanin and proliferation assays, immunostaining, Fontana-Masson staining, RT-qPCR, western blot, and whole-transcriptome RNA sequencing). We identified that treatment with PDE4is was associated with increased melanocyte proliferation and melanization in both in vitro models and with increase in the melanogenic genes and proteins expression in cultured melanocytes. These effects were found to be enhanced by addition of α-melanocyte-stimulating hormone. Our findings support the further evaluation of PDE4is with or without α-melanocyte-stimulating hormone agonists in vitiligo trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Colorado, Aurora, Colorado, USA.
- Department of Pediatrics Endocrinology, University of Colorado, Aurora, Colorado, USA.
- Department of Dermatology, University of Colorado, Aurora, Colorado, USA; Gates Center for Regenerative Medicine, University of Colorado, Aurora, Colorado, USA.
- Pfizer Pharmaceutical, Herzlyia Pituach, Israel.
- Pfizer Brasil, São Paulo, Brazil.
- Pfizer R&D UK, Tadworth, United Kingdom.
Förderung
- Pfizer
- University of Colorado
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Goldstein, N. B., Berk, Z. B. K., Tomb, L. C., Hu, J., Hoaglin, L. G., Roop, D. R., Adiri, R., Zhuang, Y., Canosa, J. M., Sanders, P., Norris, D. A., Nocka, K., Cha, A., & Birlea, S. A. (2025). Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model. Journal of Investigative Dermatology, 145(4), 883-896. https://doi.org/10.1016/j.jid.2024.08.005
Vancouver
Goldstein NB, Berk ZBK, Tomb LC, Hu J, Hoaglin LG, Roop DR, et al. Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model. Journal of Investigative Dermatology. 2025;145(4):883-896. doi:10.1016/j.jid.2024.08.005
BibTeX
@article{Goldstein2025,
author = {Goldstein, Nathaniel B and Berk, Zachary B K and Tomb, Landon C and Hu, Junxiao and Hoaglin, Laura G and Roop, Dennis R and Adiri, Roni and Zhuang, Yonghua and Canosa, Juliana M and Sanders, Paul and Norris, David A and Nocka, Karl and Cha, Amy and Birlea, Stanca A},
title = {Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {4},
pages = {883--896},
doi = {10.1016/j.jid.2024.08.005}
}
EUVIMED